Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: An integrated backscatter intravascular ultrasound study

Atherosclerosis

Volumn 218, Issue 1, 2011, Pages 110-116

  Amano, Tetsuya ^a   Matsubara, Tatsuaki ^b   Uetani, Tadayuki ^a   Kato, Masataka ^a   Kato, Bunichi ^a   Yoshida, Tomohiro ^a   Harada, Ken ^a   Kumagai, Soichiro ^a   Kunimura, Ayako ^a   Shinbo, Yusaku ^a   Kitagawa, Katsuhide ^a   Ishii, Hideki ^c   Murohara, Toyoaki ^c  

^a CHUBU ROSAI HOSPITAL   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; Coronary plaque instability; Fish oil; Integrated backscatter intravascular ultrasound; Omega 3 polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LIPID; OMEGA 3 FATTY ACID;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY DISEASE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; ULTRASONOGRAPHY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 80052272215     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.05.030     Document Type: Article

References (29)

1. Kromhout D., Bosschieter E.B., de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985, 312:1205-1209.
2. Albert C.M., Hennekens C.H., O'Donnell C.J., et al. Fish consumption and risk of sudden cardiac death. JAMA 1998, 279:23-28.
3. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
4. Rissanen T., Voutilainen S., Nyyssonen K., Lakka T.A., Salonen J.T. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 2000, 102:2677-2679.
5. Sekikawa A., Ueshima H., Kadowaki T., et al. Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort. Am J Epidemiol 2007, 165:617-624.
6. Sekikawa A., Curb J.D., Ueshima H., et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 2008, 52:417-424.
7. GISSI-HF Investigators, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223-1230.
8. Yamagishi K., Iso H., Date C., et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008, 52:988-996.
9. Anand R.G., Alkadri M., Lavie C.J., Milani R.V. The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev 2008, 28:92-98.
10. Leaf A., Albert C.M., Josephson M., et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005, 112:2762-2768.
11. Kawasaki M., Takatsu H., Noda T., et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002, 105:2487-2492.
12. Okubo M., Kawasaki M., Ishihara Y., et al. Tissue characterization of coronary plaques: comparison of integrated backscatter intravascular ultrasound with virtual histology intravascular ultrasound. Circ J 2008, 72:1631-1639.
13. Okubo M., Kawasaki M., Ishihara Y., et al. Development of integrated backscatter intravascular ultrasound for tissue characterization of coronary plaques. Ultrasound Med Biol 2008, 34:655-663.
14. Amano T., Matsubara T., Uetani T., et al. Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions: integrated backscatter intravascular ultrasound study. J Am Coll Cardiol 2007, 49:1149-1156.
15. Sano K., Kawasaki M., Ishihara Y., et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2006, 47:734-741.
16. Amano T., Matsubara T., Uetani T., et al. Lipid-rich plaques predict non-target-lesion ischemic events in patients undergoing percutaneous coronary intervention. Circ J 2010, 75:157-166.
17. Kawasaki M., Hattori A., Ishihara Y., et al. Tissue characterization of coronary plaques and assessment of thickness of fibrous cap using integrated backscatter intravascular ultrasound: comparison with histology and optical coherence tomography. Circ J 2010, 74:2641-2648.
18. Hirai A., Terano T., Hamazaki T., et al. The effects of the oral administration of fish oil concentrate on the release and the metabolism of [14C] arachidonic acid and [14C] eicosapentaenoic acid by human platelets. Thrombus Res 1982, 28:285-298.
19. Tamura Y., Hirai A., Terano T., et al. Clinical and epidemiological studies of eicosapentaenoic acid (EPA) in Japan. Prog Lipid Res 1986, 25:461-466.
20. Hamazaki T., Hirai A., Terano T., et al. Effects of orally administered ethyl ester of eicosapentaenoic acid (EPA; C20:5, omega-3) on PGI2-like substance production by rat aorta. Prostaglandins 1982, 23:557-567.
21. Okuda Y., Kawashima K., Sawada T., et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997, 232:487-491.
22. Terano T., Shiina T., Tamura Y. Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Lipids 1996, 31:301-304.
23. Thies F., Garry J.M., Yaqoob P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361:477-485.
24. Cawood A.L., Ding R., Napper F.L., et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis 2010, 212:252-259.
25. Okuda Y., Mizutani M., Ogawa M., et al. Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus. J Diabetes Complications 1996, 10:280-287.
26. Kaur G., Cameron-Smith D., Garg M., Sinclair A.J. Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog Lipid Res 2011, 50:28-34.
27. Kanayasu-Toyoda T., Morita I., Murota S. Docosapentaenoic acid (22:5, n-3) is a potent stimulator of endothelial cell migration on pretreatment in vitro. Prostaglandins Leukot Essent Fatty Acids 1996, 54:319-325.
28. Kromhout D., Giltay E.J., Geleijnse J.M. n-3 fatty acids cardiovascular events after myocardial infarction. N Engl J Med 2010, 363:2015-2026. Alpha Omega Trial Group.
29. Cheruvu P.K., Finn A.V., Gardner C., et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 2007, 50:940-949.